First National Bank & Trust Co. of Newtown Has $353,000 Position in Colgate-Palmolive (NYSE:CL)

First National Bank & Trust Co. of Newtown reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 4.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,429 shares of the company’s stock after selling 200 shares during the period. First National Bank & Trust Co. of Newtown’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. &PARTNERS grew its holdings in Colgate-Palmolive by 0.7% during the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after purchasing an additional 129 shares during the period. West Branch Capital LLC boosted its holdings in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after buying an additional 132 shares during the period. Gladstone Institutional Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock valued at $476,000 after buying an additional 133 shares during the period. First Foundation Advisors boosted its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after buying an additional 136 shares during the period. Finally, Waldron Private Wealth LLC boosted its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after buying an additional 140 shares during the period. 80.41% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. UBS Group increased their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. Finally, Citigroup raised their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at approximately $25,330,892.58. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the completion of the transaction, the chief executive officer now owns 301,343 shares in the company, valued at approximately $25,330,892.58. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock worth $19,505,099 in the last ninety days. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $0.49 during midday trading on Friday, hitting $86.70. 2,112,654 shares of the company traded hands, compared to its average volume of 4,519,123. The stock has a market cap of $71.27 billion, a price-to-earnings ratio of 31.19, a PEG ratio of 3.26 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The firm’s fifty day moving average price is $87.02 and its 200-day moving average price is $80.67. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.37.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same period in the previous year, the firm posted $0.77 EPS. The firm’s revenue was up 6.9% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.